AI chatbots are assessed by how well they improve health, patient experience, and clinic efficiency, but there’s no agreement on how to measure any of these, so studies use different and often unproven methods.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review could determine which validated tools are most commonly used to measure each domain and whether consensus exists on core metrics.
A systematic review of 150+ studies evaluating AI chatbots, extracting all outcome measures used for clinical outcomes (e.g., HbA1c, symptom scores), patient satisfaction (e.g., CSQ-8, SUS), and operational efficiency (e.g., staff time, cost per interaction), then mapping frequency and validation status of each tool.
An RCT using validated tools could demonstrate whether a chatbot improves a standardized, clinically meaningful outcome in each domain.
A multicenter RCT with 300 patients using an AI chatbot for hypertension management, measuring clinical outcome via HbA1c (validated), patient satisfaction via CSQ-8 (validated), and operational efficiency via staff time logs (validated by time-motion study), all pre-specified and standardized across sites.
A cohort study could track whether validated tools consistently detect changes in chatbot impact across diverse settings.
A prospective cohort study across 15 clinics using AI chatbots, all required to measure clinical outcomes with HbA1c or PHQ-9, satisfaction with CSQ-8, and efficiency with standardized time-motion logs, over 18 months.
A cross-sectional survey could estimate the proportion of studies using validated versus non-validated tools to measure each domain.
A survey of 200 published studies on AI chatbots in healthcare, classifying each outcome measure as validated (e.g., published psychometric properties) or non-validated (e.g., custom Likert scale), and reporting frequency by domain.
Expert consensus could recommend a minimum set of validated tools for each domain to standardize future evaluations.
A Delphi consensus process with 40 experts in digital health, clinical outcomes, and health services research, over three rounds, to agree on a core set of validated tools for measuring clinical, satisfaction, and efficiency outcomes of AI chatbots.